Literature DB >> 2243141

Human neutrophil cytochrome b light chain (p22-phox). Gene structure, chromosomal location, and mutations in cytochrome-negative autosomal recessive chronic granulomatous disease.

M C Dinauer1, E A Pierce, G A Bruns, J T Curnutte, S H Orkin.   

Abstract

A membrane-bound cytochrome b, a heterodimer formed by a 91-kD glycoprotein (heavy chain) and a 22-kD polypeptide (light chain), is an essential component of the phagocyte NADPH-oxidase responsible for superoxide generation. Cytochrome b is absent in two subgroups of chronic granulomatous disease (CGD), an inherited disorder characterized by the lack of oxidase activity. Mutations in the cytochrome heavy chain gene, encoded by the CYBB locus in Xp21.1, result in the X-linked form of CGD. A rare subgroup of autosomal recessive CGD also lacks cytochrome b (A- CGD), but the genetic defect has not previously been identified. In order to search for possible mutations in the cytochrome light chain locus, CYBA, the structure of this gene was characterized. The CYBA locus was localized to 16q24, and the approximately 600-bp open reading frame determined to be encoded by six exons that span approximately 8.5 kb. Three unrelated patients with A- CGD were studied for evidence of mutations in the light chain gene. One patient, whose parents were first cousins, was homozygous for a large deletion that removed all but the extreme 5' coding sequence of the gene. The other two patients had a grossly normal light chain transcript on Northern blot of mononuclear cell RNA. The light chain transcript was amplified by the polymerase chain reaction and sequenced. One patient was a compound heterozygote for two alleles containing point mutations in the open reading frame that predict a frame shift and a nonconservative amino acid replacement, respectively. The second patient, whose parents were second cousins, was homozygous for a different single-base substitution resulting in another nonconservative amino acid change. These results indicate that A- CGD can results from defects in the gene encoding the 22-kD light chain of the phagocyte cytochrome b.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2243141      PMCID: PMC296926          DOI: 10.1172/JCI114898

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  39 in total

Review 1.  The electron transport chain of the microbicidal oxidase of phagocytic cells and its involvement in the molecular pathology of chronic granulomatous disease.

Authors:  A W Segal
Journal:  J Clin Invest       Date:  1989-06       Impact factor: 14.808

2.  Primary structure and unique expression of the 22-kilodalton light chain of human neutrophil cytochrome b.

Authors:  C A Parkos; M C Dinauer; L E Walker; R A Allen; A J Jesaitis; S H Orkin
Journal:  Proc Natl Acad Sci U S A       Date:  1988-05       Impact factor: 11.205

3.  Purification and some properties of the small subunit of cytochrome b558 from human neutrophils.

Authors:  T Yamaguchi; T Hayakawa; M Kaneda; K Kakinuma; A Yoshikawa
Journal:  J Biol Chem       Date:  1989-01-05       Impact factor: 5.157

4.  Cytosolic components of the respiratory burst oxidase: resolution of four components, two of which are missing in complementing types of chronic granulomatous disease.

Authors:  J T Curnutte; P J Scott; L A Mayo
Journal:  Proc Natl Acad Sci U S A       Date:  1989-02       Impact factor: 11.205

5.  Absence of both the 91kD and 22kD subunits of human neutrophil cytochrome b in two genetic forms of chronic granulomatous disease.

Authors:  C A Parkos; M C Dinauer; A J Jesaitis; S H Orkin; J T Curnutte
Journal:  Blood       Date:  1989-05-01       Impact factor: 22.113

6.  Phosphorylation of the oxidase-related 48K phosphoprotein family in the unusual autosomal cytochrome-negative and X-linked cytochrome-positive types of chronic granulomatous disease.

Authors:  N Okamura; S E Malawista; R L Roberts; H Rosen; H D Ochs; B M Babior; J T Curnutte
Journal:  Blood       Date:  1988-08       Impact factor: 22.113

7.  A phosphoprotein of Mr 47,000, defective in autosomal chronic granulomatous disease, copurifies with one of two soluble components required for NADPH:O2 oxidoreductase activity in human neutrophils.

Authors:  B G Bolscher; R van Zwieten; I M Kramer; R S Weening; A J Verhoeven; D Roos
Journal:  J Clin Invest       Date:  1989-03       Impact factor: 14.808

8.  Two forms of autosomal chronic granulomatous disease lack distinct neutrophil cytosol factors.

Authors:  H Nunoi; D Rotrosen; J I Gallin; H L Malech
Journal:  Science       Date:  1988-12-02       Impact factor: 47.728

9.  Two cytosolic neutrophil oxidase components absent in autosomal chronic granulomatous disease.

Authors:  B D Volpp; W M Nauseef; R A Clark
Journal:  Science       Date:  1988-12-02       Impact factor: 47.728

10.  Genetic variants of chronic granulomatous disease: prevalence of deficiencies of two cytosolic components of the NADPH oxidase system.

Authors:  R A Clark; H L Malech; J I Gallin; H Nunoi; B D Volpp; D W Pearson; W M Nauseef; J T Curnutte
Journal:  N Engl J Med       Date:  1989-09-07       Impact factor: 91.245

View more
  80 in total

Review 1.  Chronic granulomatous disease.

Authors:  D Goldblatt; A J Thrasher
Journal:  Clin Exp Immunol       Date:  2000-10       Impact factor: 4.330

Review 2.  The molecular pathology of primary immunodeficiencies.

Authors:  Megan S Lim; Kojo S J Elenitoba-Johnson
Journal:  J Mol Diagn       Date:  2004-05       Impact factor: 5.568

3.  Towards routine screening of rare genetic diseases: the example of chronic granulomatous disease.

Authors:  Marie José Stasia
Journal:  J Mol Diagn       Date:  2010-03-19       Impact factor: 5.568

4.  A p47-phox pseudogene carries the most common mutation causing p47-phox- deficient chronic granulomatous disease.

Authors:  A Görlach; P L Lee; J Roesler; P J Hopkins; B Christensen; E D Green; S J Chanock; J T Curnutte
Journal:  J Clin Invest       Date:  1997-10-15       Impact factor: 14.808

Review 5.  Nox5 and the regulation of cellular function.

Authors:  David J R Fulton
Journal:  Antioxid Redox Signal       Date:  2009-10       Impact factor: 8.401

6.  X-Linked chronic granulomatous disease: mutations in the CYBB gene encoding the gp91-phox component of respiratory-burst oxidase.

Authors:  J Rae; P E Newburger; M C Dinauer; D Noack; P J Hopkins; R Kuruto; J T Curnutte
Journal:  Am J Hum Genet       Date:  1998-06       Impact factor: 11.025

Review 7.  Nox enzymes in immune cells.

Authors:  William M Nauseef
Journal:  Semin Immunopathol       Date:  2008-05-01       Impact factor: 9.623

Review 8.  Mechanisms for the activation/electron transfer of neutrophil NADPH-oxidase complex and molecular pathology of chronic granulomatous disease.

Authors:  S Umeki
Journal:  Ann Hematol       Date:  1994-06       Impact factor: 3.673

9.  Exercise training, NADPH oxidase p22phox gene polymorphisms, and hypertension.

Authors:  Deborah L Feairheller; Michael D Brown; Joon-Young Park; Tina E Brinkley; Samar Basu; James M Hagberg; Robert E Ferrell; Nicola M Fenty-Stewart
Journal:  Med Sci Sports Exerc       Date:  2009-07       Impact factor: 5.411

10.  IKKalpha, IKKbeta, and NEMO/IKKgamma are each required for the NF-kappa B-mediated inflammatory response program.

Authors:  Xiang Li; Paul E Massa; Adedayo Hanidu; Gregory W Peet; Patrick Aro; Ann Savitt; Sheenah Mische; Jun Li; Kenneth B Marcu
Journal:  J Biol Chem       Date:  2002-09-06       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.